The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration

Vincenzo Guarino, Filippo Causa, Paolo A. Netti, Gabriela Ciapetti, Stefania Pagani, Desiree Martini, Nicola Baldini, Luigi Ambrosio

Research output: Contribution to journalArticle

Abstract

Highly porous composites made up of biodegradable poly-ε-caprolactone (PCL) and stoichiometric hydroxyapatite (HA) particles have been developed as substrate for bone-tissue regeneration. The processing technique consists of phase inversion and particulate (salt crystals) leaching. Three different HA contents (13, 20 and 26 vol %) in PCL-based composite were considered in this study. Pore microstructure with fully interconnected network and pore sizes ranging around a few hundred of μm (macroporosity) was obtained as a result of salt particles removal by leaching process. Several microns (microporosity) porosity was also created through phase inversion of polymer solution. Total porosity up to 95% was achieved. Human marrow stromal cells (MSC) were seeded onto porous PCL-based composites for 1-5 weeks and cultured in osteogenic medium. MSC were able to adhere and grow on PCL-based substrates with a plateau at 3-4 weeks. However, the small effect of bioactive signals on the biological response evaluated in MSC cell culture suggests a prior role of topography on the biological response. Importantly, the presence of HA as a bioactive solid signal determines an increase of mechanical properties. On the overall, the results indicated that porous PCL-based composites are potential candidate for bone substitution with beneficial influence on structural characteristics by solid signal addition.

Original languageEnglish
Pages (from-to)548-557
Number of pages10
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume86
Issue number2
DOIs
Publication statusPublished - Aug 2008

Fingerprint

Tissue regeneration
Bone Regeneration
Durapatite
Hydroxyapatite
Scaffolds
Bone
Bone and Bones
Stromal Cells
Composite materials
Leaching
Bone Marrow
Porosity
Salts
Microporosity
Substrates
Polymer solutions
Cell culture
Topography
Pore size
Substitution reactions

Keywords

  • Bone
  • Composite/hard tissue
  • Hydoxy(1)lapatite
  • Scaffolds
  • Stem/progenitor cells

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration. / Guarino, Vincenzo; Causa, Filippo; Netti, Paolo A.; Ciapetti, Gabriela; Pagani, Stefania; Martini, Desiree; Baldini, Nicola; Ambrosio, Luigi.

In: Journal of Biomedical Materials Research - Part B Applied Biomaterials, Vol. 86, No. 2, 08.2008, p. 548-557.

Research output: Contribution to journalArticle

@article{2fbac5b4317446c0b40bcea9436eaab9,
title = "The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration",
abstract = "Highly porous composites made up of biodegradable poly-ε-caprolactone (PCL) and stoichiometric hydroxyapatite (HA) particles have been developed as substrate for bone-tissue regeneration. The processing technique consists of phase inversion and particulate (salt crystals) leaching. Three different HA contents (13, 20 and 26 vol {\%}) in PCL-based composite were considered in this study. Pore microstructure with fully interconnected network and pore sizes ranging around a few hundred of μm (macroporosity) was obtained as a result of salt particles removal by leaching process. Several microns (microporosity) porosity was also created through phase inversion of polymer solution. Total porosity up to 95{\%} was achieved. Human marrow stromal cells (MSC) were seeded onto porous PCL-based composites for 1-5 weeks and cultured in osteogenic medium. MSC were able to adhere and grow on PCL-based substrates with a plateau at 3-4 weeks. However, the small effect of bioactive signals on the biological response evaluated in MSC cell culture suggests a prior role of topography on the biological response. Importantly, the presence of HA as a bioactive solid signal determines an increase of mechanical properties. On the overall, the results indicated that porous PCL-based composites are potential candidate for bone substitution with beneficial influence on structural characteristics by solid signal addition.",
keywords = "Bone, Composite/hard tissue, Hydoxy(1)lapatite, Scaffolds, Stem/progenitor cells",
author = "Vincenzo Guarino and Filippo Causa and Netti, {Paolo A.} and Gabriela Ciapetti and Stefania Pagani and Desiree Martini and Nicola Baldini and Luigi Ambrosio",
year = "2008",
month = "8",
doi = "10.1002/jbm.b.31055",
language = "English",
volume = "86",
pages = "548--557",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - The role of hydroxyapatite as solid signal on performance of PCL porous scaffolds for bone tissue regeneration

AU - Guarino, Vincenzo

AU - Causa, Filippo

AU - Netti, Paolo A.

AU - Ciapetti, Gabriela

AU - Pagani, Stefania

AU - Martini, Desiree

AU - Baldini, Nicola

AU - Ambrosio, Luigi

PY - 2008/8

Y1 - 2008/8

N2 - Highly porous composites made up of biodegradable poly-ε-caprolactone (PCL) and stoichiometric hydroxyapatite (HA) particles have been developed as substrate for bone-tissue regeneration. The processing technique consists of phase inversion and particulate (salt crystals) leaching. Three different HA contents (13, 20 and 26 vol %) in PCL-based composite were considered in this study. Pore microstructure with fully interconnected network and pore sizes ranging around a few hundred of μm (macroporosity) was obtained as a result of salt particles removal by leaching process. Several microns (microporosity) porosity was also created through phase inversion of polymer solution. Total porosity up to 95% was achieved. Human marrow stromal cells (MSC) were seeded onto porous PCL-based composites for 1-5 weeks and cultured in osteogenic medium. MSC were able to adhere and grow on PCL-based substrates with a plateau at 3-4 weeks. However, the small effect of bioactive signals on the biological response evaluated in MSC cell culture suggests a prior role of topography on the biological response. Importantly, the presence of HA as a bioactive solid signal determines an increase of mechanical properties. On the overall, the results indicated that porous PCL-based composites are potential candidate for bone substitution with beneficial influence on structural characteristics by solid signal addition.

AB - Highly porous composites made up of biodegradable poly-ε-caprolactone (PCL) and stoichiometric hydroxyapatite (HA) particles have been developed as substrate for bone-tissue regeneration. The processing technique consists of phase inversion and particulate (salt crystals) leaching. Three different HA contents (13, 20 and 26 vol %) in PCL-based composite were considered in this study. Pore microstructure with fully interconnected network and pore sizes ranging around a few hundred of μm (macroporosity) was obtained as a result of salt particles removal by leaching process. Several microns (microporosity) porosity was also created through phase inversion of polymer solution. Total porosity up to 95% was achieved. Human marrow stromal cells (MSC) were seeded onto porous PCL-based composites for 1-5 weeks and cultured in osteogenic medium. MSC were able to adhere and grow on PCL-based substrates with a plateau at 3-4 weeks. However, the small effect of bioactive signals on the biological response evaluated in MSC cell culture suggests a prior role of topography on the biological response. Importantly, the presence of HA as a bioactive solid signal determines an increase of mechanical properties. On the overall, the results indicated that porous PCL-based composites are potential candidate for bone substitution with beneficial influence on structural characteristics by solid signal addition.

KW - Bone

KW - Composite/hard tissue

KW - Hydoxy(1)lapatite

KW - Scaffolds

KW - Stem/progenitor cells

UR - http://www.scopus.com/inward/record.url?scp=47949128969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47949128969&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.31055

DO - 10.1002/jbm.b.31055

M3 - Article

C2 - 18335435

AN - SCOPUS:47949128969

VL - 86

SP - 548

EP - 557

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 2

ER -